Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
622.00    -12.00 (-1.89%)
Bid:
622.00
Ask:
624.00
Spread: 2.00 (0.322%)
Market Cap: £502.84m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

12 Aug 2025 16:29

RNS Number : 0489V
Bloomsbury Publishing PLC
12 August 2025
 

12 August 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

Sale of shares following the vesting and exercise of options under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

 

The Company announced on 11 August 2025 that the conditional share award granted in August 2022 under the 2014 PSP vested at 87% of the maximum on 10 August 2025.

Nigel Newton, Chief Executive and PDMR, acquired 112,472 ordinary shares of 1.25 pence in the Company ("Ordinary Shares") (comprising 103,492 vested 2014 PSP shares and 8,980 dividend equivalent shares, both for nil consideration). Penny Scott-Bayfield, Group Finance Director and PDMR, acquired 70,252 Ordinary Shares (comprising 64,643 vested 2014 PSP shares and 5,609 dividend equivalent shares, both for nil consideration).

On 12 August 2025, Mr Newton and Ms Scott-Bayfield sold 50,867 and 33,185 Ordinary Shares respectively at a share price of £4.764739 per share in order to fund the tax liabilities and administrative fees arising on vesting. Mr Newton and Ms Scott-Bayfield retained the balance of 61,605 and 37,067 Ordinary Shares respectively.

Following these transactions, the shareholdings of Mr Newton and Ms Scott-Bayfield's (including persons closely associated) in the Company are as follows:

PDMR

 

Total shareholding in the Company

Percentage of the Company's issued share capital

Nigel Newton

1,690,596 Ordinary Shares

2.07%

Penny Scott-Bayfield

260,442 Ordinary Shares

0.32%

 

This vesting was satisfied through the transfer of shares from the Bloomsbury Employee Benefit Trust.

 

Notifications

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

50,867

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

33,185

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDIRDBDGUD
Date   Source Headline
18th Jun 201812:50 pmRNSAnnual Financial Report
7th Jun 201810:33 amRNSBloomsbury author wins major prize
1st Jun 20185:03 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
18th May 20183:23 pmRNSBlock Listing Six Monthly Return
8th May 20187:00 amRNSBloomsbury and Spotify announce partnership
1st May 20186:25 pmRNSAcquisition of IB Tauris & Co. Limited
1st May 20187:00 amRNSAcquisition of IBT Tauris & Co. Limited
19th Apr 20187:00 amRNSBoard Appointment
19th Mar 20184:37 pmRNSTrading Update
21st Dec 20177:00 amRNSDirectorate Change
17th Nov 201711:44 amRNSBlock listing Interim Review
2nd Nov 201712:25 pmRNSHolding(s) in Company
24th Oct 20177:00 amRNSHalf-year Report
2nd Oct 20173:22 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSInterim Results Date Change
5th Sep 20174:57 pmRNSDirector/PDMR Shareholding
11th Aug 20172:24 pmRNSDirector/PDMR Shareholding
28th Jul 201712:56 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:52 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSDirector/PDMR Shareholding
18th Jul 20171:19 pmRNSResults of voting on resolutions at the AGM
18th Jul 20177:00 amRNSTrading Statement
4th Jul 20172:45 pmRNSDirector/PDMR Shareholding
19th Jun 20179:55 amRNSAnnual Financial Report
16th Jun 20177:00 amRNSBoard Appointment
19th May 20174:44 pmRNS6 Month Blocklisting Return
18th May 20177:00 amRNSFinal Results
23rd Mar 20171:47 pmRNSHolding(s) in Company
20th Jan 20177:00 amRNSBoard Appointment
4th Jan 20177:15 amRNSEmployee Benefit Trust purchase of shares
13th Dec 20164:53 pmRNSDirector/PDMR Shareholding
13th Dec 20164:52 pmRNSDirector/PDMR Shareholding
13th Dec 20164:50 pmRNSDirector/PDMR Shareholding
13th Dec 20164:46 pmRNSDirector/PDMR Shareholding
18th Nov 201610:35 amRNSBlock Listing Six Monthly Return
1st Nov 20164:08 pmRNSHolding(s) in Company
1st Nov 20162:58 pmRNSHolding(s) in Company
27th Oct 20167:00 amRNSHalf-year Report
4th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Sep 20164:30 pmRNSPro forma historic results
31st Aug 20163:09 pmRNSTotal Voting Rights
23rd Aug 20162:14 pmRNSApplication for Admission
16th Aug 20169:55 amRNSHolding(s) in Company
19th Jul 20161:24 pmRNSResults of voting on resolutions at the AGM
18th Jul 20163:15 pmRNSHolding(s) in Company
13th Jul 20167:00 amRNSCapital Markets Day and Business Update
4th Jul 20165:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.